Addex Therapeutics (ADXN)

• Market cap: $8.33M
• 1 day: 1.30%
• 5 days: -4.88%
• 1 month: 6.13%
• 3 months: 6.57%
• 6 months: -27.33%
• Year to date: 3.32%
• 1 year: 1.83%
• 5 years: -94.65%
• 10 years: -96.55%
• Sector: Healthcare
• Industry: Biotechnology

About: Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.

Employees: 23

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

680% more capital invested

Capital invested by funds: $13.6K [Q3] → $106K (+$92.2K) [Q4]

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

67% more funds holding

Funds holding: 3 [Q3] → 5 (+2) [Q4]

0.01% more ownership

Funds ownership: 0% [Q3] → 0.01% (+0.01%) [Q4]